User profiles for Alejandro Cisterna-García
 | Alejandro Cisterna GarcíaPhD, Universidad de Murcia Verified email at um.es Cited by 61 |
A predictive model for hospitalization and survival to COVID-19 in a retrospective population-based study
A Cisterna-García, A Guillén-Teruel, M Caracena… - Scientific Reports, 2022 - nature.com
The development of tools that provide early triage of COVID-19 patients with minimal use of
diagnostic tests, based on easily accessible data, can be of vital importance in reducing …
diagnostic tests, based on easily accessible data, can be of vital importance in reducing …
ASL expression in ALDH1A1+ neurons in the substantia nigra metabolically contributes to neurodegenerative phenotype
S Lerner, R Eilam, L Adler, J Baruteau, T Kreiser… - Human genetics, 2021 - Springer
Argininosuccinate lyase (ASL) is essential for the NO-dependent regulation of tyrosine
hydroxylase (TH) and thus for catecholamine production. Using a conditional mouse model with …
hydroxylase (TH) and thus for catecholamine production. Using a conditional mouse model with …
Functional genomics provide key insights to improve the diagnostic yield of hereditary ataxia
Improvements in functional genomic annotation have led to a critical mass of neurogenetic
discoveries. This is exemplified in hereditary ataxia, a heterogeneous group of disorders …
discoveries. This is exemplified in hereditary ataxia, a heterogeneous group of disorders …
[HTML][HTML] Genome-wide association study stratified by MAPT haplotypes identifies potential novel loci in Parkinson's disease
Objective: To identify genetic factors that may modify the effects of the MAPT locus in
Parkinson’s disease (PD). Methods: We used data from the International Parkinson’s Disease …
Parkinson’s disease (PD). Methods: We used data from the International Parkinson’s Disease …
[PDF][PDF] Cell-free RNA signatures predict Alzheimer's disease
There is a need for affordable, scalable, and specific blood-based biomarkers for Alzheimer's
disease that can be applied to a population level. We have developed and validated …
disease that can be applied to a population level. We have developed and validated …
Genome-wide epistasis analysis in Parkinson's disease between populations with different genetic ancestry reveals significant variant-variant interactions
Genome-wide association studies (GWAS) have increased our understanding of Parkinson’s
disease (PD) genetics through the identification of common disease-associated variants. …
disease (PD) genetics through the identification of common disease-associated variants. …
PhenoLinker: Phenotype-Gene Link Prediction and Explanation using Heterogeneous Graph Neural Networks
JLM Andreu, L Bernal, AF Skarmeta, M Ryten… - arXiv preprint arXiv …, 2024 - arxiv.org
The association of a given human phenotype to a genetic variant remains a critical challenge
for biology. We present a novel system called PhenoLinker capable of associating a score …
for biology. We present a novel system called PhenoLinker capable of associating a score …
PhenoLinker: Phenotype-Gene Link Prediction and Explanation using Heterogeneous Graph Neural Networks
…, M Ryten, S Álvarez, A Cisterna García… - Available at SSRN …, 2024 - papers.ssrn.com
The association of a given human phenotype to a genetic variant remains a critical challenge
for biology. We present a novel system called PhenoLinker capable of associating a score …
for biology. We present a novel system called PhenoLinker capable of associating a score …
Preclinical Alzheimer's Disease accurate prediction using plasma cell‐free RNA sequences
A Cisterna‐García, HH Chen, J Norton… - Alzheimer's & …, 2023 - Wiley Online Library
Background Cerebrospinal fluid (CSF) Alzheimer’s disease (AD) biomarkers are used to
clinically diagnose AD with an accuracy of 70‐80%. However, they are invasive and expensive …
clinically diagnose AD with an accuracy of 70‐80%. However, they are invasive and expensive …
Plasma cell‐free RNA: a new non‐invasive biomarker for Parkinson's disease
A Beric, A Cisterna‐García, HH Chen… - Alzheimer's & …, 2023 - Wiley Online Library
Background Parkinson’s disease (PD) is the second‐most common neurodegenerative disorder,
after Alzheimer disease (AD). We aimed to create a model that can predict PD with high …
after Alzheimer disease (AD). We aimed to create a model that can predict PD with high …
